Listen

Foundation News

Clinical Trial of Neural Stem Cell Treatment for Dry AMD Authorized by the FDA

February 07, 2012

The treatment is designed to preserve vision in people with age-related macular degeneration by keeping rods and cones healthy.
Foundation Funding Developer of "Slimy" Gene Therapy for Restoring Sight

February 02, 2012

In pre-clinical studies, genes from algae are being used in a cutting-edge therapy known as ‘optogenetics.’
Success in a Canine Lab Study Moves a Gene Therapy for X-linked RP Closer to a Clinical Trial

January 31, 2012
Sustained Delivery Technology for Lucentis Performing Well in Early Clinical Trial

January 26, 2012
Participants in the First Stem Cell Clinical Trials for Retinal Disease Show Improved Vision

January 24, 2012
Foundation Fighting Blindness To Honor A Former Maryland Governor and Football Star at the Baltimore Dining in the Dark

January 24, 2012
Pennsylvania-Florida Team Reports Promising Three-Year Results for LCA Clinical Trial

January 13, 2012
Foods with a High Glycemic Index May Increase Risk of AMD

January 04, 2012

Diet truly does matter, according to a new study, in which mice eating foods that <span>spike</span> blood sugar experienced unhealthy retinal changes.
New FDA-Approved Wet AMD Treatment Requires Fewer Eye Injections

November 21, 2011

People with wet age-related macular degeneration now have another treatment option in Eylea™, which, during clinical studies, proved effective in bi-monthly doses.
Genable Receives $6.8 Million Investment to Develop Gene Therapy for Dominant RP

November 14, 2011

Building on previous Foundation funding, the company is planning a clinical trial aimed at treating a form of the disease that’s affected families for generations.
Argus II Retinal Prosthesis Implanted for the First Time Commercially in Europe

November 03, 2011

Several months after winning marketing approval in Europe, the Argus II, a prosthetic device known as “the bionic retina,” is implanted for the first time commercially in Italy
Lending the Foundation's AMD Expertise to AARP Radio

October 19, 2011

The Foundation’s Chief Research Officer contributes to a popular AARP radio program heard across the nation.
Researchers Identify Major Culprit in the Development of AMD

October 11, 2011
Gene Therapy Revives Cones Long After They Stop Working

October 04, 2011
Newly Found Gene is Common Cause of RP in People of Jewish Descent

August 11, 2011
Looking for Genes in All the Right Places

July 20, 2011
Emerging Treatment Gets the Message Right

July 07, 2011
Gene Therapy Clinical Trials Underway for Stargardt Disease and AMD

June 22, 2011

The first-ever gene therapy clinical trial for Stargardt disease, a juvenile form of macular degeneration, is underway at Oregon Health & Science University’s (OHSU) Casey Eye Institute in Portland. Peter Francis, M.D., Ph.D., the principal investigator for the Phase I/IIa study, reports that the trial’s first participant has received the treatment.
Emerging Treatment Stabilizes Vision in People with Dry AMD

March 26, 2011
Patients With Inherited Retinal Degenerative Diseases Caused By ABCA4 Gene Mutations Should Use Caution When Taking More Than a Daily Recommended Amount of Vitamin A Supplements
New Study Paves Way for Treating Second Eye in Gene Therapy Clinical Trial
FDA-Approved Drug Moving into Clinical Trial for Treatment of RP

Valproic acid, a drug which has shown promise for preserving vision in people affected by autosomal dominant forms of retinitis pigmentosa (adRP), is moving into a Foundation-funded multicenter clinical trial this fall.
Latest Update: Gene Therapy Restores Significant Vision to Children with LCA

Gene therapy has taken another major step forward as a treatment for retinal diseases. Researchers conducting the landmark gene therapy clinical trial at The Children’s Hospital of Philadelphia (CHOP) have just reported that 12 people with Leber congenital amaurosis have now been successfully treated and are experiencing sustained, and in many cases significant, improvement in their vision.
Latest Update: Childhood Rediscovered: Gene Therapy Restores Vision for 9-year old with LCA

When it was his turn to take the stage at a press conference at The Children’s Hospital of Philadelphia (CHOP), Corey Haas got up from his seat in the auditorium and walked effortlessly up the four steps in front of him. Without hesitation, he crossed the stage, stepped around the table and took his seat next to Dr. Jean Bennett. His white cane was nowhere to be seen.
Now They See - Breaking News from the Foundation Fighting Blindness

DONATE

Theme

Foundation News

Pages